Zentiva eyes production hub in Turkey; S. Africa hands out $667M in HIV drug contracts;

@FiercePharma: J&J won't enforce its Prezista patent in Africa, provided generics makers sell quality copies. Article | Follow @FiercePharma

> Sanofi ($SNY) generics subsidiary Zentiva, based in Prague, wants to turn Turkey into a generics hub by shifting production of most meds for export to that country. Report

> South Africa awarded $667 million in HIV drug supply contracts to domestic drugmakers, with Aspen Pharmacare and Adcock Ingram taking the largest shares. Report

> Eli Lilly's ($LLY) erectile dysfunction drug Cialis may have found another use: Improving blood flow in patients with a type of muscular dystrophy. Report

> A French appeals court upheld a €197,000 ($255,760) ruling against GlaxoSmithKline ($GSK), in the case of a patient who claimed the Parkinson's treatment Requip caused his gambling addiction. Report

> Mylan ($MYL) won FDA approval for its version of version of the Pfizer ($PFE) overactive bladder drugs Detrol. Report

Medical Device News

 @FierceMedDev: Roche Dx scores top marks for glucose meter satisfaction. More | Follow @FierceMedDev

@MarkHFierce: In 2012, medical device and Dx investment in China kicked into overdrive. Find out how, and why. Editor's Corner | Follow @MarkHFierce

 @DamianFierce: We've talked a lot about M&A targets in devices, but what about Sunshine Heart? C-Pulse could be worth $2.5B. News | Follow @DamianFierce

> Board approves Abbott split, effective Jan. 1, 2013. Report

> Bracco launches Class I recall of pre-filled syringes over stroke risk. Story

Biotech News

 @FierceBiotech: New feature: 23andMe sets stage for stronger ties with pharma. Editor's Corner | Follow @FierceBiotech

 @JohnCFierce:  So rida goes down in flames in europe as well. Merck pulls app. More | Follow @JohnCFierce

 @RyanMFierce: Monkeys lost 10% of their body weight on $AMGN's experimental antibody in 11-week study. News | Follow @RyanMFierce

> Lilly chief prods China's drug regulators on clinical development timelines. Report

> Johnson & Johnson unit wins FDA panel backing for new tuberculosis therapy. News

> Amarin scraps another Vascepa deadline as red-hot buyout rumors smolder. Story

Pharma Manufacturing News

> Bracco Diagnostics recalls angiography drug over particulates. Story

> Eli Lilly CEO endorses anti-counterfeiting campaign in China. Report

> Capsugel gets organic designation for European products. News

Vaccines News

> Virus found in dogs may fuel new vaccines. Report

> CureVac, German scientists take aim at faster flu vaccine. Article

> Danish-made TB vaccine sickens Romanian children. Item

> Selecta inks $900M immunotherapy deal with Sanofi. Story

And Finally... Philadelphia Phillies catcher Carlos "Chooch" Ruiz was suspended for taking Adderall, considered a violation of Major League Baseball's performance-enhancing drug policy. Report

Suggested Articles

With generics at the gates, Novartis’ Gilenya secured a breath of fresh air—and protection for its blockbuster sales—with a federal injunction.

Akorn has been slammed with another FDA warning letter even as it is in the process of renegotiating its loans with lenders.

Horizon Therapeutics is preparing for the potential launch of inflammatory eye drug teprotumumab with team building.